Haber M - Search Results

1

Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies.

Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK. Ferdinands JM, et al. Among authors: haber m. Epidemiology. 2013 Jul;24(4):530-7. doi: 10.1097/EDE.0b013e3182953065. Epidemiology. 2013. PMID: 23732734

2

The case test-negative design for studies of the effectiveness of influenza vaccine.

Foppa IM, Haber M, Ferdinands JM, Shay DK. Foppa IM, et al. Among authors: haber m. Vaccine. 2013 Jun 26;31(30):3104-9. doi: 10.1016/j.vaccine.2013.04.026. Epub 2013 Apr 23. Vaccine. 2013. PMID: 23624093

3

A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.

Haber M, An Q, Foppa IM, Shay DK, Ferdinands JM, Orenstein WA. Haber M, et al. Epidemiol Infect. 2015 May;143(7):1417-26. doi: 10.1017/S0950268814002179. Epub 2014 Aug 22. Epidemiol Infect. 2015. PMID: 25147970 Free PMC article.

4

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, Orenstein WA. Orenstein EW, et al. Int J Epidemiol. 2007 Jun;36(3):623-31. doi: 10.1093/ije/dym021. Epub 2007 Apr 2. Int J Epidemiol. 2007. PMID: 17403908

5

The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.

Foppa IM, Ferdinands JM, Chaves SS, Haber MJ, Reynolds SB, Flannery B, Fry AM. Foppa IM, et al. Among authors: haber mj. Int J Epidemiol. 2016 Dec 1;45(6):2052-2059. doi: 10.1093/ije/dyw022. Int J Epidemiol. 2016. PMID: 26979985 Free PMC article.

6

Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic.

Haber MJ, Shay DK, Davis XM, Patel R, Jin X, Weintraub E, Orenstein E, Thompson WW. Haber MJ, et al. Emerg Infect Dis. 2007 Apr;13(4):581-9. doi: 10.3201/eid1304.060828. Emerg Infect Dis. 2007. PMID: 17553273 Free PMC article.

7

Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Arinaminpathy N, Kim IK, Gargiullo P, Haber M, Foppa IM, Gambhir M, Bresee J. Arinaminpathy N, et al. Among authors: haber m. Am J Epidemiol. 2017 Jul 1;186(1):92-100. doi: 10.1093/aje/kwx037. Am J Epidemiol. 2017. PMID: 28369163 Free PMC article.

8

Challenges in estimating influenza vaccine effectiveness.

Ainslie KEC, Haber M, Orenstein WA. Ainslie KEC, et al. Among authors: haber m. Expert Rev Vaccines. 2019 Jun;18(6):615-628. doi: 10.1080/14760584.2019.1622419. Epub 2019 May 31. Expert Rev Vaccines. 2019. PMID: 31116070 Free PMC article. Review.

9

A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies.

Ainslie KEC, Shi M, Haber M, Orenstein WA. Ainslie KEC, et al. Among authors: haber m. Am J Epidemiol. 2019 Feb 1;188(2):451-460. doi: 10.1093/aje/kwy240. Am J Epidemiol. 2019. PMID: 30329006 Free PMC article.

10

Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community.

Ainslie KEC, Haber MJ, Malosh RE, Petrie JG, Monto AS. Ainslie KEC, et al. Stat Med. 2018 Mar 15;37(6):970-982. doi: 10.1002/sim.7558. Epub 2017 Nov 28. Stat Med. 2018. PMID: 29193179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters